A-Alpha Bio Revenue and Competitors

Seattle, WA USA

Location

$46M

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • A-Alpha Bio's estimated annual revenue is currently $17.5M per year.(i)
  • A-Alpha Bio's estimated revenue per employee is $277,571
  • A-Alpha Bio's total funding is $46M.

Employee Data

  • A-Alpha Bio has 63 Employees.(i)
  • A-Alpha Bio grew their employee count by 0% last year.

A-Alpha Bio's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Co-founder & CTOReveal Email/Phone
3
Chief Business OfficerReveal Email/Phone
4
VP Data ScienceReveal Email/Phone
5
VP Technical Operations & EngineeringReveal Email/Phone
6
Data Scientist IIReveal Email/Phone
7
Sr. Director, R&D BiologicsReveal Email/Phone
8
Chief Business OfficerReveal Email/Phone
9
Director Machine Learning ResearchReveal Email/Phone
10
Senior Director, Finance & OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M13-13%N/AN/A
#2
$1M14-22%$38.1MN/A
#3
$2.6M14-30%N/AN/A
#4
$0.9M6-33%N/AN/A
#5
$67M205-13%$63.6MN/A
#6
$2.6M140%N/AN/A
#7
$16.4M5920%N/AN/A
#8
$3.5M2377%$14.6MN/A
#9
$7.7M3163%N/AN/A
#10
$3.5M2364%$18.4MN/A
Add Company

What Is A-Alpha Bio?

At A-Alpha Bio, we aim to accelerate target discovery, library screening, and preclinical drug characterization by providing cell-based tools for quantitative and high-throughput measurements of protein interactions. Current approaches for measuring protein interactions are insufficient for many drug development applications due to low accuracy or throughput. We are a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck. AlphaSeq is a revolutionary cell-based platform technology that will fundamentally change the way that protein interactions are measured. We are seeking industry partnerships to evaluate the use of AlphaSeq for a variety of drug development applications. A-Alpha Bio, Inc. was founded in 2017 as a spinout from the University of Washington's Institute for Protein Design and Center for Synthetic Biology.

keywords:N/A

$46M

Total Funding

63

Number of Employees

$17.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

A-Alpha Bio News

2022-04-17 - Health Innovation of the Year: 5 finalists at the GeekWire Awards span fields and approaches

The five finalists are: A- Alpha Bio, Parse Biosciences, Tasso, Truveta, and the University of Washington's Institute for Protein Design.

2022-04-13 - Startups are back on campus: UW job fair brings out big crowd for internship and job opportunities

Sam Halabiya, a volunteer at SoundBio Labs. (GeekWire Photo / Julie Emory) ... Cameron Cordray, senior research associate at A-Alpha Bio.

2022-03-30 - Funding News: Enzyme design startup lands $33M; addiction recovery company raises $3M

Arzeda is one of several protein engineering startups founded on research from the lab, including A-Alpha Bio, Cyrus Biotechnology and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.2M6313%N/A
#2
$15.3M635%N/A
#3
$7.6M637%N/A
#4
$3.5M6319%N/A
#5
$11.6M6315%N/A